Assessing emerging markets’ vulnerability to financial crisis

Since 2011, emerging economies have experienced a significant and largely unexpected growth slowdown. They have also faced several episodes of financial turmoil over the past two years. This paper examines the developments in 28 emerging economies since the global financial crisis and assesses their...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:369 EGFR SIGNALING IMPAIRS THE ANTIVIRAL ACTIVITY OF INTERFERON-ALPHA. - 2013 JPMOD : a social science forum of world issues. - Amsterdam [u.a.]
1. Verfasser: Pitterle, Ingo (VerfasserIn)
Weitere Verfasser: Haufler, Fabio (BerichterstatterIn), Hong, Pingfan (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015transfer abstract
Zugriff auf das übergeordnete Werk:369 EGFR SIGNALING IMPAIRS THE ANTIVIRAL ACTIVITY OF INTERFERON-ALPHA
Schlagworte:Policy challenges Emerging markets Growth slowdown Vulnerabilities Financial turmoil
Umfang:17
LEADER 01000caa a22002652 4500
001 ELV039594262
003 DE-627
005 20230625225353.0
007 cr uuu---uuuuu
008 180603s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jpolmod.2015.03.010  |2 doi 
028 5 2 |a GBVA2015003000017.pica 
035 |a (DE-627)ELV039594262 
035 |a (ELSEVIER)S0161-8938(15)00038-1 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 |a 340 
082 0 4 |a 340  |q DE-600 
082 0 4 |a 610  |q VZ 
082 0 4 |a 610  |q VZ 
084 |a 44.44  |2 bkl 
100 1 |a Pitterle, Ingo  |e verfasserin  |4 aut 
245 1 0 |a Assessing emerging markets’ vulnerability to financial crisis 
264 1 |c 2015transfer abstract 
300 |a 17 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a Since 2011, emerging economies have experienced a significant and largely unexpected growth slowdown. They have also faced several episodes of financial turmoil over the past two years. This paper examines the developments in 28 emerging economies since the global financial crisis and assesses their financial vulnerabilities. We analyze several factors that have contributed to the growth slowdown and the increased financial vulnerabilities: the exposure to the commodity price decline; the combination of weakening investment and rapidly rising leverage in the private sector; and increased political instability and uncertainty. Addressing these issues is critical for both short-term stability and longer-term development prospects. 
520 |a Since 2011, emerging economies have experienced a significant and largely unexpected growth slowdown. They have also faced several episodes of financial turmoil over the past two years. This paper examines the developments in 28 emerging economies since the global financial crisis and assesses their financial vulnerabilities. We analyze several factors that have contributed to the growth slowdown and the increased financial vulnerabilities: the exposure to the commodity price decline; the combination of weakening investment and rapidly rising leverage in the private sector; and increased political instability and uncertainty. Addressing these issues is critical for both short-term stability and longer-term development prospects. 
650 7 |a Policy challenges  |2 Elsevier 
650 7 |a Emerging markets  |2 Elsevier 
650 7 |a Growth slowdown  |2 Elsevier 
650 7 |a Vulnerabilities  |2 Elsevier 
650 7 |a Financial turmoil  |2 Elsevier 
700 1 |a Haufler, Fabio  |4 oth 
700 1 |a Hong, Pingfan  |4 oth 
773 0 8 |i Enthalten in  |n Elsevier  |a Lupberger, J. ELSEVIER  |t 369 EGFR SIGNALING IMPAIRS THE ANTIVIRAL ACTIVITY OF INTERFERON-ALPHA  |d 2013  |d JPMOD : a social science forum of world issues  |g Amsterdam [u.a.]  |w (DE-627)ELV016667247 
773 1 8 |g volume:37  |g year:2015  |g number:3  |g pages:484-500  |g extent:17 
856 4 0 |u https://doi.org/10.1016/j.jpolmod.2015.03.010  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a SSG-OLC-PHA 
912 |a GBV_ILN_21 
912 |a GBV_ILN_70 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2470 
936 b k |a 44.44  |j Parasitologie  |x Medizin  |q VZ 
951 |a AR 
952 |d 37  |j 2015  |e 3  |h 484-500  |g 17 
953 |2 045F  |a 340